Magnesium in PDB 2pzp: Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome
Enzymatic activity of Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome
All present enzymatic activity of Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome:
2.7.10.1;
Protein crystallography data
The structure of Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome, PDB code: 2pzp
was solved by
H.Chen,
M.Mohammadi,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
25.00 /
2.40
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
105.410,
114.021,
64.392,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
21.4 /
25.1
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome
(pdb code 2pzp). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 4 binding sites of Magnesium where determined in the
Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome, PDB code: 2pzp:
Jump to Magnesium binding site number:
1;
2;
3;
4;
Magnesium binding site 1 out
of 4 in 2pzp
Go back to
Magnesium Binding Sites List in 2pzp
Magnesium binding site 1 out
of 4 in the Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg301
b:2.0
occ:1.00
|
ND2
|
A:ASN631
|
2.2
|
16.2
|
1.0
|
O
|
A:HOH803
|
2.2
|
25.0
|
1.0
|
O1A
|
A:ACP300
|
2.2
|
25.0
|
1.0
|
OD2
|
A:ASP644
|
2.2
|
26.0
|
1.0
|
O3G
|
A:ACP300
|
2.4
|
20.6
|
1.0
|
O
|
A:HOH795
|
2.5
|
22.7
|
1.0
|
CG
|
A:ASN631
|
3.3
|
16.5
|
1.0
|
CG
|
A:ASP644
|
3.3
|
27.7
|
1.0
|
PA
|
A:ACP300
|
3.5
|
26.3
|
1.0
|
PG
|
A:ACP300
|
3.5
|
25.4
|
1.0
|
OD1
|
A:ASN631
|
3.6
|
17.3
|
1.0
|
CB
|
A:ASP644
|
3.7
|
26.3
|
1.0
|
O2G
|
A:ACP300
|
3.7
|
19.2
|
1.0
|
O3A
|
A:ACP300
|
3.8
|
24.3
|
1.0
|
O
|
A:HOH833
|
4.0
|
34.0
|
1.0
|
MG
|
A:MG302
|
4.1
|
2.0
|
1.0
|
O
|
A:HOH797
|
4.2
|
12.3
|
1.0
|
O
|
A:ARG630
|
4.3
|
18.4
|
1.0
|
O
|
A:HOH819
|
4.4
|
25.9
|
1.0
|
C3B
|
A:ACP300
|
4.4
|
23.9
|
1.0
|
O1B
|
A:ACP300
|
4.4
|
20.7
|
1.0
|
OD1
|
A:ASP644
|
4.4
|
28.6
|
1.0
|
PB
|
A:ACP300
|
4.5
|
23.8
|
1.0
|
O5'
|
A:ACP300
|
4.5
|
23.9
|
1.0
|
O2A
|
A:ACP300
|
4.5
|
22.8
|
1.0
|
CB
|
A:ASN631
|
4.6
|
17.4
|
1.0
|
NE
|
A:ARG630
|
4.6
|
30.4
|
1.0
|
C5'
|
A:ACP300
|
4.7
|
25.0
|
1.0
|
OD1
|
A:ASP626
|
4.7
|
19.7
|
1.0
|
O1G
|
A:ACP300
|
4.7
|
22.0
|
1.0
|
CA
|
A:ASN631
|
4.8
|
18.6
|
1.0
|
C
|
A:ARG630
|
4.9
|
19.4
|
1.0
|
|
Magnesium binding site 2 out
of 4 in 2pzp
Go back to
Magnesium Binding Sites List in 2pzp
Magnesium binding site 2 out
of 4 in the Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg302
b:2.0
occ:1.00
|
O1B
|
A:ACP300
|
2.2
|
20.7
|
1.0
|
O
|
A:HOH799
|
2.3
|
28.8
|
1.0
|
O
|
A:HOH825
|
2.3
|
30.6
|
1.0
|
O2G
|
A:ACP300
|
2.4
|
19.2
|
1.0
|
OD2
|
A:ASP644
|
2.4
|
26.0
|
1.0
|
OD1
|
A:ASP644
|
2.4
|
28.6
|
1.0
|
CG
|
A:ASP644
|
2.8
|
27.7
|
1.0
|
PB
|
A:ACP300
|
3.4
|
23.8
|
1.0
|
PG
|
A:ACP300
|
3.5
|
25.4
|
1.0
|
C3B
|
A:ACP300
|
3.6
|
23.9
|
1.0
|
O
|
A:HOH810
|
4.0
|
30.5
|
1.0
|
O3G
|
A:ACP300
|
4.0
|
20.6
|
1.0
|
O
|
A:HOH797
|
4.1
|
12.3
|
1.0
|
NZ
|
A:LYS517
|
4.1
|
34.8
|
1.0
|
MG
|
A:MG301
|
4.1
|
2.0
|
1.0
|
O
|
A:HOH784
|
4.2
|
25.4
|
1.0
|
O3A
|
A:ACP300
|
4.2
|
24.3
|
1.0
|
CB
|
A:ASP644
|
4.3
|
26.3
|
1.0
|
CA
|
A:GLY646
|
4.5
|
23.9
|
1.0
|
O1A
|
A:ACP300
|
4.6
|
25.0
|
1.0
|
O2B
|
A:ACP300
|
4.6
|
23.6
|
1.0
|
PA
|
A:ACP300
|
4.7
|
26.3
|
1.0
|
O1G
|
A:ACP300
|
4.7
|
22.0
|
1.0
|
N
|
A:GLY646
|
4.7
|
23.9
|
1.0
|
O2A
|
A:ACP300
|
4.8
|
22.8
|
1.0
|
O
|
A:HOH795
|
4.9
|
22.7
|
1.0
|
OD1
|
A:ASP626
|
5.0
|
19.7
|
1.0
|
|
Magnesium binding site 3 out
of 4 in 2pzp
Go back to
Magnesium Binding Sites List in 2pzp
Magnesium binding site 3 out
of 4 in the Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg301
b:2.0
occ:1.00
|
O2G
|
B:ACP300
|
2.2
|
23.8
|
1.0
|
O
|
B:HOH792
|
2.3
|
24.2
|
1.0
|
O2A
|
B:ACP300
|
2.3
|
21.5
|
1.0
|
O
|
B:HOH797
|
2.3
|
21.1
|
1.0
|
OD2
|
B:ASP644
|
2.3
|
14.9
|
1.0
|
ND2
|
B:ASN631
|
2.3
|
16.8
|
1.0
|
CG
|
B:ASP644
|
3.4
|
16.6
|
1.0
|
PG
|
B:ACP300
|
3.4
|
21.4
|
1.0
|
CG
|
B:ASN631
|
3.4
|
16.5
|
1.0
|
PA
|
B:ACP300
|
3.5
|
21.0
|
1.0
|
O1G
|
B:ACP300
|
3.7
|
22.8
|
1.0
|
O3A
|
B:ACP300
|
3.8
|
21.3
|
1.0
|
OD1
|
B:ASN631
|
3.8
|
21.1
|
1.0
|
CB
|
B:ASP644
|
3.8
|
15.8
|
1.0
|
O
|
B:HOH819
|
4.0
|
26.1
|
1.0
|
O
|
B:HOH786
|
4.1
|
16.9
|
1.0
|
MG
|
B:MG302
|
4.2
|
2.0
|
1.0
|
C3B
|
B:ACP300
|
4.2
|
23.0
|
1.0
|
O
|
B:ARG630
|
4.4
|
15.3
|
1.0
|
PB
|
B:ACP300
|
4.4
|
23.7
|
1.0
|
O1B
|
B:ACP300
|
4.4
|
24.1
|
1.0
|
OD1
|
B:ASP644
|
4.4
|
14.2
|
1.0
|
O5'
|
B:ACP300
|
4.5
|
24.2
|
1.0
|
O1A
|
B:ACP300
|
4.5
|
18.6
|
1.0
|
O3G
|
B:ACP300
|
4.6
|
21.2
|
1.0
|
C5'
|
B:ACP300
|
4.6
|
24.8
|
1.0
|
NE
|
B:ARG630
|
4.7
|
30.6
|
1.0
|
CB
|
B:ASN631
|
4.7
|
17.4
|
1.0
|
CA
|
B:ASN631
|
4.9
|
18.6
|
1.0
|
O
|
B:HOH793
|
4.9
|
26.6
|
1.0
|
OD1
|
B:ASP626
|
4.9
|
20.0
|
1.0
|
C
|
B:ARG630
|
4.9
|
18.5
|
1.0
|
|
Magnesium binding site 4 out
of 4 in 2pzp
Go back to
Magnesium Binding Sites List in 2pzp
Magnesium binding site 4 out
of 4 in the Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Crystal Structure of Fgf Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible For Crouzon Syndrome within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg302
b:2.0
occ:1.00
|
O
|
B:HOH793
|
2.2
|
26.6
|
1.0
|
O1B
|
B:ACP300
|
2.3
|
24.1
|
1.0
|
O
|
B:HOH825
|
2.4
|
29.1
|
1.0
|
O1G
|
B:ACP300
|
2.4
|
22.8
|
1.0
|
OD1
|
B:ASP644
|
2.5
|
14.2
|
1.0
|
OD2
|
B:ASP644
|
2.5
|
14.9
|
1.0
|
CG
|
B:ASP644
|
2.8
|
16.6
|
1.0
|
PB
|
B:ACP300
|
3.3
|
23.7
|
1.0
|
C3B
|
B:ACP300
|
3.3
|
23.0
|
1.0
|
PG
|
B:ACP300
|
3.4
|
21.4
|
1.0
|
O2G
|
B:ACP300
|
3.9
|
23.8
|
1.0
|
O
|
B:HOH786
|
4.0
|
16.9
|
1.0
|
O
|
B:HOH805
|
4.1
|
22.5
|
1.0
|
MG
|
B:MG301
|
4.2
|
2.0
|
1.0
|
O3A
|
B:ACP300
|
4.2
|
21.3
|
1.0
|
CB
|
B:ASP644
|
4.3
|
15.8
|
1.0
|
NZ
|
B:LYS517
|
4.4
|
30.0
|
1.0
|
O2B
|
B:ACP300
|
4.4
|
23.6
|
1.0
|
O
|
B:HOH815
|
4.4
|
22.4
|
1.0
|
CA
|
B:GLY646
|
4.5
|
16.3
|
1.0
|
O2A
|
B:ACP300
|
4.6
|
21.5
|
1.0
|
PA
|
B:ACP300
|
4.6
|
21.0
|
1.0
|
O3G
|
B:ACP300
|
4.7
|
21.2
|
1.0
|
O1A
|
B:ACP300
|
4.7
|
18.6
|
1.0
|
O
|
B:HOH797
|
4.8
|
21.1
|
1.0
|
N
|
B:GLY646
|
4.8
|
15.7
|
1.0
|
|
Reference:
H.Chen,
J.Ma,
W.Li,
A.V.Eliseenkova,
C.Xu,
T.A.Neubert,
W.T.Miller,
M.Mohammadi.
A Molecular Brake in the Kinase Hinge Region Regulates the Activity of Receptor Tyrosine Kinases. Mol.Cell V. 27 717 2007.
ISSN: ISSN 1097-2765
PubMed: 17803937
DOI: 10.1016/J.MOLCEL.2007.06.028
Page generated: Wed Aug 14 02:23:43 2024
|